Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
AMS's Cash to Debt is ranked lower than
69% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.14 vs. AMS: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
AMS' s 10-Year Cash to Debt Range
Min: 0   Max: 1.04
Current: 0.04

0
1.04
Equity to Asset 0.37
AMS's Equity to Asset is ranked higher than
56% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. AMS: 0.37 )
Ranked among companies with meaningful Equity to Asset only.
AMS' s 10-Year Equity to Asset Range
Min: -0.34   Max: 0.43
Current: 0.37

-0.34
0.43
F-Score: 5
Z-Score: 0.68
M-Score: -3.45
WACC vs ROIC
9.11%
0.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 3.29
AMS's Operating margin (%) is ranked lower than
53% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. AMS: 3.29 )
Ranked among companies with meaningful Operating margin (%) only.
AMS' s 10-Year Operating margin (%) Range
Min: -0.32   Max: 45.83
Current: 3.29

-0.32
45.83
Net-margin (%) -4.71
AMS's Net-margin (%) is ranked lower than
61% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. AMS: -4.71 )
Ranked among companies with meaningful Net-margin (%) only.
AMS' s 10-Year Net-margin (%) Range
Min: -6.18   Max: 57.1
Current: -4.71

-6.18
57.1
ROE (%) -3.50
AMS's ROE (%) is ranked lower than
56% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. AMS: -3.50 )
Ranked among companies with meaningful ROE (%) only.
AMS' s 10-Year ROE (%) Range
Min: -4.64   Max: 1872.38
Current: -3.5

-4.64
1872.38
ROA (%) -1.12
AMS's ROA (%) is ranked lower than
58% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. AMS: -1.12 )
Ranked among companies with meaningful ROA (%) only.
AMS' s 10-Year ROA (%) Range
Min: -1.37   Max: 70.39
Current: -1.12

-1.37
70.39
ROC (Joel Greenblatt) (%) 0.96
AMS's ROC (Joel Greenblatt) (%) is ranked lower than
59% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 8.51 vs. AMS: 0.96 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -0.09   Max: 36.8
Current: 0.96

-0.09
36.8
Revenue Growth (3Y)(%) -14.00
AMS's Revenue Growth (3Y)(%) is ranked lower than
51% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: -12.00 vs. AMS: -14.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -44.3   Max: 27.8
Current: -14

-44.3
27.8
EBITDA Growth (3Y)(%) -12.10
AMS's EBITDA Growth (3Y)(%) is ranked higher than
61% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMS: -12.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -34.3   Max: 18.4
Current: -12.1

-34.3
18.4
» AMS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.60
AMS's P/B is ranked higher than
97% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. AMS: 0.60 )
Ranked among companies with meaningful P/B only.
AMS' s 10-Year P/B Range
Min: 0.26   Max: 1.99
Current: 0.6

0.26
1.99
P/S 0.85
AMS's P/S is ranked higher than
67% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. AMS: 0.85 )
Ranked among companies with meaningful P/S only.
AMS' s 10-Year P/S Range
Min: 0.24   Max: 2.02
Current: 0.85

0.24
2.02
PFCF 7.80
AMS's PFCF is ranked higher than
92% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 46.50 vs. AMS: 7.80 )
Ranked among companies with meaningful PFCF only.
AMS' s 10-Year PFCF Range
Min: 0.86   Max: 56
Current: 7.8

0.86
56
POCF 2.07
AMS's POCF is ranked higher than
98% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 35.89 vs. AMS: 2.07 )
Ranked among companies with meaningful POCF only.
AMS' s 10-Year POCF Range
Min: 0.59   Max: 4.56
Current: 2.07

0.59
4.56
EV-to-EBIT 79.64
AMS's EV-to-EBIT is ranked lower than
54% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 47.98 vs. AMS: 79.64 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s 10-Year EV-to-EBIT Range
Min: -1026.5   Max: 89
Current: 79.64

-1026.5
89
Current Ratio 0.77
AMS's Current Ratio is ranked lower than
58% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.97 vs. AMS: 0.77 )
Ranked among companies with meaningful Current Ratio only.
AMS' s 10-Year Current Ratio Range
Min: 0.36   Max: 4.13
Current: 0.77

0.36
4.13
Quick Ratio 0.77
AMS's Quick Ratio is ranked lower than
55% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.87 vs. AMS: 0.77 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s 10-Year Quick Ratio Range
Min: 0.36   Max: 4.13
Current: 0.77

0.36
4.13
Days Sales Outstanding 91.24
AMS's Days Sales Outstanding is ranked lower than
61% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 59.97 vs. AMS: 91.24 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s 10-Year Days Sales Outstanding Range
Min: 13.48   Max: 93.87
Current: 91.24

13.48
93.87

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.60
AMS's Price/Tangible Book is ranked higher than
98% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. AMS: 0.60 )
Ranked among companies with meaningful Price/Tangible Book only.
AMS' s 10-Year Price/Tangible Book Range
Min: 0.27   Max: 2.45
Current: 0.6

0.27
2.45
Price/DCF (Projected) 0.30
AMS's Price/DCF (Projected) is ranked higher than
100% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMS: 0.30 )
Ranked among companies with meaningful Price/DCF (Projected) only.
AMS' s 10-Year Price/DCF (Projected) Range
Min: 0.15   Max: 1.02
Current: 0.3

0.15
1.02
Price/Median PS Value 1.10
AMS's Price/Median PS Value is ranked higher than
66% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. AMS: 1.10 )
Ranked among companies with meaningful Price/Median PS Value only.
AMS' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 4.67
Current: 1.1

0.14
4.67
Earnings Yield (Greenblatt) 1.30
AMS's Earnings Yield (Greenblatt) is ranked lower than
61% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 3.20 vs. AMS: 1.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
AMS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 9.9
Current: 1.3

1.1
9.9
Forward Rate of Return (Yacktman) 20.33
AMS's Forward Rate of Return (Yacktman) is ranked higher than
91% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMS: 20.33 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
AMS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.6   Max: 56.7
Current: 20.33

1.6
56.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.
» More Articles for AMS

Headlines

Articles On GuruFocus.com
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
AMSC Reports Fourth Quarter and Fiscal 2014 Financial Results and Provides Business Outlook May 28 2015
Anglo shuffles leadership at its South African business May 28 2015
AMERICAN SHARED HOSPITAL SERVICES Financials May 22 2015
AMSC to Report Fourth Quarter and Full Year Financial Results on May 28, 2015 May 21 2015
AMSC Announces Contract From U.S. Navy for High Temperature Superconductor (HTS) Equipment May 19 2015
PLATINUM WEEK-Rising output turns screw on S.African platinum sector May 18 2015
PLATINUM WEEK-Rising output turns screw on S.African platinum sector May 17 2015
10-Q for American Shared Hospital Services May 16 2015
S.Africa mines minister says concerned about retrenchments May 14 2015
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... May 14 2015
American Shared Hospital Services Reports First Quarter Results May 14 2015
South Africa mines minister says concerned about retrenchments May 14 2015
Q1 2015 American Shared Hospital Services Earnings Release - Time Not Supplied May 14 2015
Protests halt output for 3rd day at Atlatsa's S.Africa JV mine May 13 2015
Amplats, Atlatsa S.Africa JV mine losing 700 PGM ounces a day due to protest May 13 2015
American Shared Hospital Services Announces First Quarter 2015 Results Earnings Conference Call May 11 2015
S.Africa's Baroka prepares up to $150 mln for Atlatsa's mine stake - source May 11 2015
Atlatsa says output at S.African joint venture mine hit by protest May 11 2015
AMSC Announces New D-VAR(R) System Orders May 05 2015
S.Africa's Amplats to cut 474 jobs in restructuring plan Apr 29 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK